
Medical AI faces a critical measurement crisis where models that excel on standardized tests often fail to perform safely in complex, real-world clinical settings. Unlike general consumer AI, medical tools require rigorous, independent evaluation to detect subtle biases and misalignments that can lead to harmful patient outcomes. Engy Ziedan, co-founder and chief scientific officer of Protege, argues that relying on static benchmarks is insufficient because medical technology evolves rapidly and requires continuous, live-wire monitoring. Protege addresses this by acting as an independent arbiter, using proprietary, non-contaminated clinical data to test AI performance across specific medical subnodes. This approach ensures that AI agents are vetted for clinical adequacy before deployment, moving beyond simple accuracy metrics to prioritize patient safety and reliable decision-making in high-stakes healthcare environments.
Sign in to continue reading, translating and more.
Open full episode in Podwise